Roflo, Crestila .

HRN: 21-92-03  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/13/2022
METRONIDAZOLE 500MG (TAB)
09/13/2022
09/20/2022
PO
1tab
Q8H
TMSAF
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Intra-abdominalReproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: